BridgeBio Pharma Inc (BBIO) distance from 200-day Simple Moving Average is $33.05: Right on the Precipice

BridgeBio Pharma Inc (NASDAQ: BBIO) started the day on Wednesday, with a price increase of 0.92% at $46.19, before settling in for the price of $45.77 at the close. Taking a more long-term approach, BBIO posted a 52-week range of $21.72-$48.68.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -3.04%. Meanwhile, its Annual Earning per share during the time was -3.04%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -1.81%. This publicly-traded company’s shares outstanding now amounts to $189.83 million, simultaneously with a float of $160.86 million. The organization now has a market capitalization sitting at $8.77 billion. At the time of writing, stock’s 50-day Moving Average stood at $40.20, while the 200-day Moving Average is $33.05.

BridgeBio Pharma Inc (BBIO) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. BridgeBio Pharma Inc’s current insider ownership accounts for 15.28%, in contrast to 83.50% institutional ownership. According to the most recent insider trade that took place on Jul 02 ’25, this organization’s Chief Executive Officer sold 40,000 shares at the rate of 42.73, making the entire transaction reach 1,709,050 in total value, affecting insider ownership by 955,686. Preceding that transaction, on Jul 01 ’25, Company’s Chief Executive Officer sold 40,000 for 42.54, making the whole transaction’s value amount to 1,701,400. This particular insider is now the holder of 975,686 in total.

BridgeBio Pharma Inc (BBIO) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.

BridgeBio Pharma Inc’s EPS decrease for this current 12-month fiscal period is -1.81% and is forecasted to reach -1.78 in the upcoming year.

BridgeBio Pharma Inc (NASDAQ: BBIO) Trading Performance Indicators

Let’s observe the current performance indicators for BridgeBio Pharma Inc (BBIO). It’s Quick Ratio in the last reported quarter now stands at 4.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 68.83.

In the same vein, BBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.53, a figure that is expected to reach -0.75 in the next quarter, and analysts are predicting that it will be -1.78 at the market close of one year from today.

Technical Analysis of BridgeBio Pharma Inc (BBIO)

If we take a close look at the recent performances of BridgeBio Pharma Inc (NASDAQ: BBIO), its last 5-days Average volume was 1.99 million that shows plunge from its year to date volume of 3.04 million. During the previous 9 days, stock’s Stochastic %D was recorded 27.47% While, its Average True Range was 59.92%.

Raw Stochastic average of BridgeBio Pharma Inc (BBIO) in the period of the previous 100 days is set at 87.76%, which indicates a major rise in contrast to 61.05% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.36 that was lower than 1.56 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.